On November 3, SKB BIO fell 6.11% in Regular Trading, trading at HK$402.2, with turnover of HK$73.42 million.
The move coincided with continued on-market share disposals by controlling shareholder Liu Gexin, a clear event-driven overhang on sentiment.
Public disclosures show Liu sold shares on each trading day from October 26 through October 30. The latest disclosed transaction was on October 30, when he sold 57,200 shares at an average price of HK$430.36, cashing out about HK$24.62 million and reducing his long position to 48.65% from 48.96% across the five-day period. Earlier filings showed additional sales of 82,800 shares on October 29, 111,700 shares on October 28, 118,800 shares on October 27, and 166,400 shares on October 26, with affiliated employee shareholding platforms also participating in selling on October 26.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments